Back to Menu
Maxillary Sinus Cancer Treatment Modalities
1.Surgical treatment
For early-stage and selected intermediate-stage patients, radical resection is performed to achieve negative margins.
2.Minimally invasive surgery
Endoscopic endonasal or robot-assisted surgery is associated with less trauma and faster recovery and is suitable for selected early tumors.
3.Radiotherapy
IMRT enables precise irradiation of the tumor while maximally sparing normal organs such as the eyes and brainstem.
4.Chemotherapy
Induction, concurrent, or adjuvant chemotherapy is used for tumor downstaging, radiosensitization, and reducing the risk of distant metastasis.
5.Targeted therapy
For example, cetuximab combined with radiotherapy may be used in selected patients with locally advanced disease.
6.Immunotherapy
PD-1 inhibitors provide a potential option for durable survival in patients with recurrent or metastatic disease.
7.Proton and heavy-ion radiotherapy
Particle therapy delivers highly conformal high-dose irradiation while sparing critical organs.
8.Multidisciplinary collaborative model
An MDT team jointly develops an individualized, sequential treatment plan.
9.Craniofacial en bloc resection
En bloc resection of tumors invading the skull base may offer a curative opportunity for locally advanced disease.
10.Functional reconstruction and rehabilitation
Microsurgical flap reconstruction repairs defects and restores swallowing, speech, and facial contour.
11.Supportive care and pain management
Implemented throughout the entire course to ensure treatment completion and improve quality of life.
Conclusion:
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that early diagnosis is pivotal for maxillary sinus cancer. Experts highlight an MDT-centered approach that integrates surgery, chemoradiotherapy, targeted and immunotherapies, and precision reconstruction in an individualized manner, enabling maximal preservation of function and appearance while pursuing tumor control and long-term high-quality survival.
Maxillary Sinus Cancer Treatment Modalities
1.Surgical treatment
For early-stage and selected intermediate-stage patients, radical resection is performed to achieve negative margins.
2.Minimally invasive surgery
Endoscopic endonasal or robot-assisted surgery is associated with less trauma and faster recovery and is suitable for selected early tumors.
3.Radiotherapy
IMRT enables precise irradiation of the tumor while maximally sparing normal organs such as the eyes and brainstem.
4.Chemotherapy
Induction, concurrent, or adjuvant chemotherapy is used for tumor downstaging, radiosensitization, and reducing the risk of distant metastasis.
5.Targeted therapy
For example, cetuximab combined with radiotherapy may be used in selected patients with locally advanced disease.
6.Immunotherapy
PD-1 inhibitors provide a potential option for durable survival in patients with recurrent or metastatic disease.
7.Proton and heavy-ion radiotherapy
Particle therapy delivers highly conformal high-dose irradiation while sparing critical organs.
8.Multidisciplinary collaborative model
An MDT team jointly develops an individualized, sequential treatment plan.
9.Craniofacial en bloc resection
En bloc resection of tumors invading the skull base may offer a curative opportunity for locally advanced disease.
10.Functional reconstruction and rehabilitation
Microsurgical flap reconstruction repairs defects and restores swallowing, speech, and facial contour.
11.Supportive care and pain management
Implemented throughout the entire course to ensure treatment completion and improve quality of life.
Conclusion:
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that early diagnosis is pivotal for maxillary sinus cancer. Experts highlight an MDT-centered approach that integrates surgery, chemoradiotherapy, targeted and immunotherapies, and precision reconstruction in an individualized manner, enabling maximal preservation of function and appearance while pursuing tumor control and long-term high-quality survival.